Breaking President Trump Honors Winter Olympians and Paralympians at White House Beau Hossler Leads Wyndham Championship, Eyes FedEx Cup Berth Tucker Carlson Unveils ‘Manifesto’ Post-Republican Party Departure Justice Department Alleges Duke Law Illegally Considered Race in Admissions Louisiana School Board and Federal Government End 61-Year Desegregation Oversight

Thursday August 6, 2026

Reporter

Outlook Therapeutics, Inc.

2Articles Published

5Communities Covered

Published Articles

Press Release

Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026

12 hours ago

Press Release

Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD

Jul 24